MEDIFAST Revenues from 2010 to 2024

MED Stock  USD 38.32  0.79  2.10%   

Projected quarterly revenue analysis

Projected quarterly revenue analysis of MEDIFAST INC provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of MEDIFAST INC match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in MEDIFAST INC's stock price.
Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.8 M, Selling General Administrative of 753.6 M or Total Revenue of 1.1 B, as well as many exotic indicators such as Short Term Coverage Ratios of 24.06, Price Earnings Ratio of 6.99 or Price To Sales Ratio of 0.65. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
  
This module can also supplement MEDIFAST INC's financial leverage analysis and stock options assessment as well as various MEDIFAST INC Technical models . Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

About MEDIFAST INC Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MEDIFAST INC income statement, its balance sheet, and the statement of cash flows. MEDIFAST INC investors use historical funamental indicators, such as MEDIFAST INC's Revenues, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may use each financial statement separately, they are all related. The changes in MEDIFAST INC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MEDIFAST INC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MEDIFAST INC Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
4.95
Earnings Share
9.1
Revenue Per Share
98.498
Quarterly Revenue Growth
(0.43)
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.